Inhibitory Effect of Angiotensin Blockade on Hepatic Fibrosis in Common Bile Duct-ligated Rats.
	    		
		   		
	    	
    	
    	
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Dong Hun PARK
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Soon Koo BAIK
			        		
			        		;
		        		
		        		
		        		
			        		Yeon Hee CHOI
			        		
			        		;
		        		
		        		
		        		
			        		Moon Young KIM
			        		
			        		;
		        		
		        		
		        		
			        		Dae Wook RHIM
			        		
			        		;
		        		
		        		
		        		
			        		Jae Woo KIM
			        		
			        		;
		        		
		        		
		        		
			        		Sang Ok KWON
			        		
			        		;
		        		
		        		
		        		
			        		Mi Yun CHO
			        		
			        		;
		        		
		        		
		        		
			        		Chul Han KIM
			        		
			        		;
		        		
		        		
		        		
			        		Seung Chan AHN
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea. baiksk@yonsei.ac.kr
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article ; English Abstract
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Fibrosis;
			        		
			        		
			        		
				        		Angiotensin-converting enzyme inhibitors;
			        		
			        		
			        		
				        		Angiotensin II type I receptor blockers;
			        		
			        		
			        		
				        		Liver;
			        		
			        		
			        		
				        		Rats
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Actins/metabolism;
				        		
			        		
				        		
					        		Angiotensin II Type 1 Receptor Blockers/administration & dosage/*therapeutic use;
				        		
			        		
				        		
					        		Animals;
				        		
			        		
				        		
					        		Bile Ducts/pathology/surgery;
				        		
			        		
				        		
					        		Captopril/administration & dosage/*therapeutic use;
				        		
			        		
				        		
					        		Fibrosis;
				        		
			        		
				        		
					        		Hydroxyproline/metabolism;
				        		
			        		
				        		
					        		Ligation;
				        		
			        		
				        		
					        		Liver/drug effects/metabolism/pathology;
				        		
			        		
				        		
					        		Liver Cirrhosis, Experimental/*drug therapy/etiology/metabolism;
				        		
			        		
				        		
					        		Losartan/administration & dosage/*therapeutic use;
				        		
			        		
				        		
					        		Male;
				        		
			        		
				        		
					        		Rats;
				        		
			        		
				        		
					        		Rats, Sprague-Dawley;
				        		
			        		
				        		
					        		Transforming Growth Factor beta/metabolism
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:The Korean Journal of Hepatology
	            		
	            		 2007;13(1):61-69
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:Korean
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	BACKGROUNDS AND AIMS: Angiotensin receptors are found on hepatic stellate cells, which participate in hepatic fibrosis. Therefore, it is presumed that angiotensin has a role in hepatic fibrosis. The aim of this study was to evaluate the effects of angiotensin blockade on inhibition of hepatic fibrosis in cirrhotic rat model. Material and METHODS: Cirrhosis with portal hypertension was produced by common bile duct ligation (BDL) in the adult Sprague-Dawley rats. They were classified into 4 groups (each group n=6) as follows; G1: BDL without drug, G2: BDL+captopril 100 mg/kg/day beginning 2 weeks after BDL, G3: BDL+captopril 100 mg/kg/day, starting just after BDL, G4: BDL+losartan 10 mg/kg/day, starting just after BDL. After 4 weeks following BDL, hepatic fibrosis was histomorphologically analyzed by Batts & Ludwig score. Alpha smooth muscle actin by immunohistochemical stain, hydroxyproline contents of liver tissue by spectrophotometry and expression of collagen, procollagen, and TGF-beta by real-time PCR were measured. RESULTS: Batts & Ludwig score were 3.8, 3.0, 2.6,and 2.6 in G1, G2, G3, and G4, respectively. The expression of alpha-SMA was significantly lower in G3 and G4 than in G1; 11.9%, 10.9%, 2.6%, and 1.1% in G1, G2, G3, and G4, respectively (p<0.05). The concentration of hydroxyproline (microgram/g liver tissue) was lower in G3 and G4 compared with G1 (p<0.05). Also, the administration of angiotensin blockade just after BDL significantly reduced the expression of collagen, procollagen, and TGF-beta mRNA. CONCLUSIONS: Angiotensin blockades are effective in the prevention of hepatic fibrosis in BDL rats.